戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                                             We developed a behavioral model to assess this mode of learni
2                                                             We developed a compartment model of the United States to simu
3                                                             We developed a computational simulation model to quantify the
4                                                             We developed a detailed kinetic model of the fatty acid synth
5                                                             We developed a dynamic microsimulation model to project HIV i
6                                                             We developed a flexible statistical model that uses patterns
7                                                             We developed a framework for modelling the effect of motivati
8                                                             We developed a hierarchical Bayesian model to estimate popula
9                                                             We developed a large animal model of MVID that has many featu
10                                                             We developed a machine learning model to identify patients at
11                                                             We developed a Markov model of patients with wild-type or var
12                                                             We developed a mathematical model of TB transmission to proje
13                                                             We developed a microsimulation model of stage-specific cancer
14                                                             We developed a minimal mathematical model demonstrating growt
15                                                             We developed a murine model of orthopaedic trauma combining t
16                                                             We developed a network model to identify plausible mechanisms
17                                                             We developed a new model based on the architecture of the sem
18                                                             We developed a new model of PD that combines a sub-toxic MPTP
19                                                             We developed a rhesus macaque model of SARS-CoV-2 infection a
20                                                             We developed a serocatalytic mathematical model to capture th
21                                                             We developed a transgenic model using site-directed insertion
22                                                             We developed a unifying model for these phenomena by training
23                                                             We developed a yeast model for ESCRT-dependent Gag release.
24 ion of these biopsies including additional features of ATI, we developed a final multivariate model with a highly signifi
25                                   Furthermore, with CLASSED we developed a context-specific model of beta-adrenergic card
26  the impact of diarrhoea on susceptibility to colonization, we developed a mouse model of variable disturbance intensity,
27                               Using these single-cell data, we developed a quantitative, probabilistic model of cone cell
28 cance of increased parasitism rate for population dynamics, we developed a host-parasitoid model.
29                                                To that end, we developed a mathematical modeling framework to simulate th
30 filtration and tubular uptake to urinary protein excretion, we developed a mathematical model of protein reabsorption in
31                                                        Here we developed a neurochemical model of dopamine receptor bindi
32                                                        Here we developed a rat model of sequential cocaine and alcohol se
33                                                       Here, we developed a computational modeling platform and software p
34                                                       Here, we developed a novel mouse model to knock down tau in neurons
35                                                       Here, we developed a pharmacophore model allowing us to assemble a
36                                                       Here, we developed a rat model of incubation of opioid craving afte
37                           To understand this heterogeneity, we developed a mathematical model.
38                             To automate hit identification, we developed a machine-learning model trained on nuclear morp
39                                     Using this information, we developed a molecular model of the arrestin-1-enolase-1 co
40 al to vertical growth, the first step in melanoma invasion, we developed a zebrafish melanoma model in which constitutive
41  investigate the role of plasmodesmata in auxin patterning, we developed a multicellular model of the Arabidopsis root ti
42                                                  Previously we developed a mouse model of GDM, however we did not evaluat
43 ial mechanisms underlying these distinct temporal profiles, we developed a reduced spiking model of sensory cortical circ
44 e learning algorithms and pathological examination reports, we developed a classification model, which has an overall acc
45                                        Using these results, we developed a decision model to estimate probability of tran
46  chromosomes and simultaneously assemble a bipolar spindle, we developed a computational model of fission-yeast mitosis.
47                                              In this study, we developed a mathematical modeling framework to quantify th
48                                              In this study, we developed a mouse model, in which murine IL-6 is overexpre
49 ere, as SARS-CoV-2 primarily infects the respiratory tract, we developed a lung organoid model using human pluripotent st
50  source partner affects the number of HIV founder variants, we developed a phylodynamic model calibrated using genetic an